Invesco
INBX icon

Invesco’s Inhibrx INBX Stock Holding History

Invesco’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Sell
23,356
-89,040
-79% -$6.6M ﹤0.01% 2660
2025
Q4 		$8.88M Buy
112,396
+94,822
+540% +$6.46M ﹤0.01% 1922
2025
Q3 		$592K Buy
17,574
+4,082
+30% +$100K ﹤0.01% 3165
2025
Q2 		$193K Buy
+13,492
New +$174K ﹤0.01% 3518
2024
Q3 		– Sell
-21,386
Closed -$303K – 3812
2024
Q2 		$303K Buy
+21,386
New +$334K ﹤0.01% 3496

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco's INBX Position: Q1 2026 in Review

Invesco reduced its Inhibrx (INBX) stake by 79% in Q1 2026, selling an estimated $6.6M and leaving 23,356 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2660.

Invesco first reported a position in INBX in Q2 2024 and has held it in 5 quarters since. The position peaked at $8.88M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Invesco held 23,356 shares of Inhibrx worth $1.57M as of Q1 2026.
  • Invesco sold 89,040 Inhibrx shares in Q1 2026, an estimated $6.6M.
  • Inhibrx made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2660 holding.
  • Invesco first reported a position in Inhibrx in Q2 2024 and has held it in 5 quarters since.
  • Invesco's Inhibrx position peaked at $8.88M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.